The second part of the day will provide focused breakout sessions on hereditary endocrine disorders, including primary hyperparathyroidism; pituitary tumours; phaeochromocytoma/paraganglioma; and endocrine neoplasia syndromes. We’ll focus on causative genes, criteria for genetic testing and management protocols for each condition using case-based vignettes.